{"id":52291,"date":"2020-07-24T00:00:00","date_gmt":"2020-07-24T00:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2669331"},"modified":"2020-07-24T00:00:00","modified_gmt":"2020-07-24T00:00:00","slug":"ventricular-assist-device-market-size-is-1-35-bn-in-2019-growing-at-a-cagr-of-11-8-during-the-forecast-period-2020-2025","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2020\/07\/24\/ventricular-assist-device-market-size-is-1-35-bn-in-2019-growing-at-a-cagr-of-11-8-during-the-forecast-period-2020-2025\/","title":{"rendered":"Ventricular Assist Device Market size is $1.35 Bn in 2019, growing at a CAGR of 11.8% during the forecast period 2020-2025"},"content":{"rendered":"

\"\"<\/p>\n

Ventricular Assist Device Market<\/a><\/strong>size is $1.35 Bn in 2019, growing at a CAGR of 11.8% during the forecast period 2020-2025. Ventricular Assist Device is a mechanical pump used to support heart function and blood flow in individuals who have weakened hearts or cardiac problems. A ventricular assist device (VAD) takes blood from a lower chamber of the heart and helps pump it into the body and vital organs. It is used to support hearts during or after surgery until it recovers, or when a patient is waiting for a heart transplant or can be a long term solution for patients who are not eligible for heart transplant. These devices are implanted in the patient’s body when ventricles fail to perform their function owing to various medical conditions such as Bundle branch block, Myocardial Infarction (MI).<\/div>\n
<\/div>\n
\n
By Type – Segment Analysis<\/strong><\/div>\n
<\/div>\n
In 2019, Left Ventricular Assist Devices (LVADs) segment dominated the Ventricular Assist Device Market in terms of revenue is estimated to grow at a CAGR of 13.7%. Left Ventricular Assist Devices (LVADs) is implanted during an open-heart surgery, where it receives blood from the left ventricle and delivers it to the aorta. It works along with the patient’s own heart. It is mostly given as a treatment option for patients with end-stage heart failure. Bridge-to-Transplant (BTT) Therapy is the most used therapy type for Left Ventricular Assist Devices (LVADs) to restore the heart failure, eliminating the need for a transplant abetting towards the market’s growth.<\/div>\n
<\/div>\n
Request for Sample of the Report @https:\/\/www.industryarc.com\/pdfdownload.php?id=16935<\/a><\/strong><\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

Report Price: $ 4500 (Single User License)<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

Geography – Segment Analysis<\/strong><\/div>\n
<\/div>\n
In 2019, the North America region dominated Ventricular Assist Device Market in terms of revenue with a market share of 52.1% owing towards owing to the presence of established payers and an increase in the number of cardiovascular disease patients in the region. This growth can be attributed towards the advanced healthcare infrastructure with technological practice, higher spending by citizens on healthcare, growing old age and cardiac patient pool, favorable government policies are key factors in the growth of the Ventricular Assist Device market. Europe is estimated to record the fastest growth rate during the forecast period 2020-2025.<\/div>\n
<\/div>\n
Drivers – Ventricular Assist Device Market<\/strong><\/div>\n
\n